ResearcherAsan Medical CenterActive in the last 2 years
Eun‐Ju Chang
Matched on ORCID iD 0000-0001-8324-5406; OpenAlex author ID A5058368777. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers
Papers 5
- Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer. Co-author DOI 10.1038/s12276-024-01231-0↗
- Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41416-024-02676-w↗
- Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-… Co-author DOI 10.1007/s00262-023-03458-8↗
- Identification of circulating myeloid cells as a potential diagnosis and recurrence marker of pancreatic ductal adenocarcinoma through the single-cell analysis Co-author DOI 10.21203/rs.3.rs-2345667/v1↗
- Characterization of Circulating IL-7R Positive Cell Populations for Early Detection of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/jcm10184157↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hyung Keun Lee · 4 shared papers, 2021–2024 · strength 0.63
- Paper Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pan… DOI 10.1038/s41416-024-02676-w↗
- Paper Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel develop… DOI 10.1007/s00262-023-03458-8↗
- Paper Characterization of Circulating IL-7R Positive Cell Populations for Early Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/jcm10184157↗
- Sung Ill Jang · 4 shared papers, 2021–2024 · strength 0.63
- Paper Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pan… DOI 10.1038/s41416-024-02676-w↗
- Paper Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel develop… DOI 10.1007/s00262-023-03458-8↗
- Paper Characterization of Circulating IL-7R Positive Cell Populations for Early Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/jcm10184157↗
- Dong Ki Lee · 4 shared papers, 2021–2024 · strength 0.63
- Paper Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pan… DOI 10.1038/s41416-024-02676-w↗
- Paper Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel develop… DOI 10.1007/s00262-023-03458-8↗
- Paper Characterization of Circulating IL-7R Positive Cell Populations for Early Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/jcm10184157↗
- Joon Seong Park · 2 shared papers, 2022–2024 · strength 0.31
- Paper Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pan… DOI 10.1038/s41416-024-02676-w↗
- Paper Identification of circulating myeloid cells as a potential diagnosis and recurrence marker of pancreatic ductal adenoca… DOI 10.21203/rs.3.rs-2345667/v1↗
- Se Seul Im · 1 shared paper, 2024 · strength 0.20
- Ji Hye Kim · 1 shared paper, 2024 · strength 0.20
- Boyun Kim · 1 shared paper, 2024 · strength 0.20
- Kyung‐Chul Choi · 1 shared paper, 2024 · strength 0.20
- Jaekyoung Son · 1 shared paper, 2024 · strength 0.20
- Jae Hee Cho · 1 shared paper, 2023 · strength 0.17
- Sun‐Hee Heo · 1 shared paper, 2021 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.